My Treatment Approach: Improving Chronic Lymphocytic Leukemia Management and Treatment Outcomes - Episode 12
Emerging Data with BTKi Resistance: Expert Insights and Treatment Implications
The panel addresses the intricacies of treating patients with chronic lymphocytic leukemia who experience treatment resistance.
Video content above is prompted by the following questions:
- Briefly discuss insights regarding emerging resistance data and its potential implications on treatment decisions/practices.
- In patients who progress on 1L therapy with BTKi, do you test for the presence of BTK resistance mutations?
- How do you interpret available data to the clinical practice setting?